Orphan Drugs Market 2015-2019

Nov 24, 2015, 15:41 ET from Reportlinker

NEW YORK, Nov. 24, 2015 /PRNewswire/ -- About orphan drugs
An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.

Technavio's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.

Technavio's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- Europe

Key vendors
- Bristol-Mayer Squibb
- Celgene
- F. Hoffmann La Roche
- Novartis
- Pfizer

Other prominent vendors
- AbbVie
- Actelion Pharmaceuticals
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Amgen
- AstraZeneca
- Baxter International
- Biogen Idec
- Celldex Therapeutics
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Intercept Pharmaceuticals
- Johnson & Johnson
- Merck
- NewLink Genetics
- Northwest Biotherapeutics
- Novo Nordisk
- Onyx Pharmaceuticals
- Sanofi
- Shire
- Synageva BioPharma
- Takeda
- Vertex Pharmaceuticals

Market driver
- Shorter development timelines
- For a full, detailed list, view our report

Market challenge
- High cost of drug development
- For a full, detailed list, view our report

Market trend
- Increased focus on biological drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Read the full report: http://www.reportlinker.com/p03391392-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker